News
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
There’s no such thing as "natural Ozempic." While supplements like psyllium, berberine, and glucomannan are paraded as ...
ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection – ...
13d
BBC Good Food on MSNWe asked 7 experts what they really think of weight loss jabsBy Vicky ChandlerOpinions on the new breed of slimming drugs, like Ozempic and Mounjaro, are strong and varied. But what about those who are really in the know?Within the last year we’ve seen a huge ...
In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...
20d
India Today on MSNAll you need to know about weight-loss surgery and medicationsWeight-loss drugs offer initial benefits but often lead to weight regain after discontinuation. Bariatric surgery provides lasting metabolic changes and better long-term health outcomes for obesity ...
In December, GLP-1 agonist tirzepatide (Zepbound) became the first drug approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity after two trials showed it reduced ...
A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...
The ARC of the hypothalamus receives and integrates circulating appetite signals. The satiety signals oxyntomodulin and PYY 3-36 cross the blood-brain barrier and act on neurons within the ARC, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results